Advertisement
Advertisement

Patricia Van Arnum

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

Advertisement

Biogen Idec, Samsung Form Biosimilars Joint Venture

December 08, 2011

Samsung and Biogen Idec agreed to invest $300 million to establish a joint venture to develop, manufacture, and market biosimilars. The deal is Samsung's latest effort to strengthen its position in biosimilars.

World Health Organization Issues Progress Report on Combating HIV/AIDS

December 07, 2011

International efforts, including improving access to medicines, have contributed to stemming the rise of HIV/AIDS in the developing world.

CSR and Sustainability in the News

December 07, 2011

A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other private and public organizations.

Technical Perspectives: Antibody Drug Conjugates

December 07, 2011

A podcast moderated by Patricia Van Arnum, executive editor of Pharmaceutical Technology.

Advertisement
Advertisement
Advertisement
Advertisement
x